We are a clinical-stage biopharmaceutical company dedicated to the discovery and development of therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. Our team finds meaning in making purposeful connections as we seek to bring forward groundbreaking therapies for patients who need them.